Genetic Engineering News -- Roche is buying Germany-based clinical lab automation firm PVT and its U.S. sales and distribution subsidiary for €65 million (about $91 million) up front, plus up to €20 million ($28 million) in performance-related milestones. The acquired firm specializes in the development of customized automation and workflow solutions for in vitro diagnostic testing in commercial and hospital laboratories. Roche says PVT’s products and expertise will bolster its position in the core laboratory field, a market it estimates was worth some $15.3 billion in 2009.
